Yantai Zhenghai Bio-Tech Co Ltd (300653) — Capital Reinvestment Ratio

Latest as of September 2025: 0.05x

Yantai Zhenghai Bio-Tech Co Ltd (300653) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥30.47 Million) in capital expenditures (CN¥1.64 Million). See cash generation quality of Yantai Zhenghai Bio-Tech Co Ltd to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥30.47 Million
CNY

Capital Expenditures

CN¥1.64 Million
CNY

Data as of

Sep 2025
Most recent filing

Yantai Zhenghai Bio-Tech Co Ltd Capital Reinvestment Ratio (2012–2024)

This chart tracks Yantai Zhenghai Bio-Tech Co Ltd's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for Yantai Zhenghai Bio-Tech Co Ltd (2012–2024)

Year-by-year Capital Reinvestment Ratio for Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see 300653 company net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.10x CN¥151.38 Million CN¥15.57 Million ▼ -41.8%
2023 0.18x CN¥180.48 Million CN¥31.88 Million ▼ -40.8%
2022 0.30x CN¥187.84 Million CN¥56.06 Million ▲ +404.9%
2021 0.06x CN¥166.13 Million CN¥9.82 Million ▼ -93.2%
2020 0.87x CN¥118.43 Million CN¥103.03 Million ▲ +44.5%
2019 0.60x CN¥103.48 Million CN¥62.31 Million ▲ +588.7%
2018 0.09x CN¥77.47 Million CN¥6.77 Million ▼ -45.9%
2017 0.16x CN¥65.47 Million CN¥10.59 Million ▼ -77.6%
2016 0.72x CN¥49.25 Million CN¥35.53 Million ▲ +467.9%
2015 0.13x CN¥45.74 Million CN¥5.81 Million ▲ +6.6%
2014 0.12x CN¥30.79 Million CN¥3.67 Million ▲ +27.9%
2013 0.09x CN¥34.38 Million CN¥3.20 Million ▼ -61.0%
2012 0.24x CN¥22.62 Million CN¥5.41 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow